ATE236405T1 - Western blot test zur identifizierung von hcmv spezifische antiköpern - Google Patents

Western blot test zur identifizierung von hcmv spezifische antiköpern

Info

Publication number
ATE236405T1
ATE236405T1 AT97939364T AT97939364T ATE236405T1 AT E236405 T1 ATE236405 T1 AT E236405T1 AT 97939364 T AT97939364 T AT 97939364T AT 97939364 T AT97939364 T AT 97939364T AT E236405 T1 ATE236405 T1 AT E236405T1
Authority
AT
Austria
Prior art keywords
identifying
western blot
hcmv
specific antibodies
blot test
Prior art date
Application number
AT97939364T
Other languages
English (en)
Inventor
Maria P Landini
Gregory T Maine
Alessandro Ripalti
Tiziana Lazzarotto
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE236405T1 publication Critical patent/ATE236405T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/559—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody through a gel, e.g. Ouchterlony technique
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
    • G01N2333/04—Varicella-zoster virus
    • G01N2333/045—Cytomegalovirus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dispersion Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT97939364T 1996-08-16 1997-08-07 Western blot test zur identifizierung von hcmv spezifische antiköpern ATE236405T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96TO000705A IT1290804B1 (it) 1996-08-16 1996-08-16 Saggio western blot perfezionato per l'individuazione di anticorpi specifici contro il virus hcmv
PCT/US1997/013942 WO1998007033A1 (en) 1996-08-16 1997-08-07 Improved western blot test for the identification of antibodies specific against the hcmv virus

Publications (1)

Publication Number Publication Date
ATE236405T1 true ATE236405T1 (de) 2003-04-15

Family

ID=11414859

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97939364T ATE236405T1 (de) 1996-08-16 1997-08-07 Western blot test zur identifizierung von hcmv spezifische antiköpern

Country Status (9)

Country Link
US (1) US6287760B1 (de)
EP (2) EP0920629B1 (de)
JP (3) JP4559542B2 (de)
AT (1) ATE236405T1 (de)
CA (1) CA2263439C (de)
DE (1) DE69720470T2 (de)
ES (1) ES2196360T3 (de)
IT (1) IT1290804B1 (de)
WO (1) WO1998007033A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3670208B2 (ja) * 2000-11-08 2005-07-13 アルプス電気株式会社 プラズマ処理装置，プラズマ処理システムおよびこれらの性能確認システム，検査方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR862472B (en) 1986-09-30 1986-10-09 Elliniko Institouto Paster Determination of antibodies specific of hsv-1 herpes or hsv-2 in human serum with the elisa technic using the specific antigen of hsv-1 or hsv-2 type in semi - clean form
EP0301141A1 (de) 1987-07-30 1989-02-01 Microbiological Research Corporation Testvorrichtung für Festphasen-Enzymimmunoassay und Verfahren zur Bestimmung von Antikörpern
US5124255A (en) * 1988-03-11 1992-06-23 Abbott Laboratories CKS method of protein synthesis
AU637097B2 (en) 1989-05-09 1993-05-20 Abbott Laboratories Process for preparing an improved western blot immunoassay
GB9014652D0 (en) 1990-07-02 1990-08-22 Wellcome Found Antigen
DE4128684A1 (de) * 1991-08-29 1993-03-04 Behringwerke Ag Hcmv-spezifische peptide, mittel dazu und ihre verwendung
IT1266740B1 (it) * 1994-07-01 1997-01-14 Maria Paola Landini Materiale proteico ricombinante legante anticorpi contro il citomegalovirus umano, reagenti diagnostici derivati da tale
DE4435789C1 (de) * 1994-10-06 1995-12-21 Biotest Ag Peptide und Fusionsproteine umfassend eine aus dem Leserahmen UL 57 des Cytomegalievirus stammende Aminosäuresequenz und diese enthaltende diagnostische Testkits
DE4426453C1 (de) 1994-07-26 1995-11-02 Biotest Ag Rekombinant hergestellte Fusionsproteine des Cytomegalievirus und diese enthaltende diagnostische Testkits
JP4108122B2 (ja) 1995-05-15 2008-06-25 アボット・ラボラトリーズ 異種蛋白質の埋込発現

Also Published As

Publication number Publication date
EP0920629A1 (de) 1999-06-09
JP2010158251A (ja) 2010-07-22
WO1998007033A1 (en) 1998-02-19
DE69720470T2 (de) 2004-02-12
EP1291357A3 (de) 2006-07-26
JP2001501457A (ja) 2001-02-06
JP4559542B2 (ja) 2010-10-06
EP1291357A2 (de) 2003-03-12
EP0920629B1 (de) 2003-04-02
JP2009060906A (ja) 2009-03-26
ITTO960705A1 (it) 1998-02-16
ES2196360T3 (es) 2003-12-16
CA2263439A1 (en) 1998-02-19
US6287760B1 (en) 2001-09-11
DE69720470D1 (de) 2003-05-08
IT1290804B1 (it) 1998-12-11
CA2263439C (en) 2008-12-02

Similar Documents

Publication Publication Date Title
ATE116006T1 (de) Synthetische antigene zum nachweis von aids.
MX9700817A (es) Secuencia viral de nucleotidos de "vr-2332" y metodos de uso.
DE3686304D1 (de) Typenspezifische papillomavirus-dns-sequenzen und peptide.
ATE366314T1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
AU571128B2 (en) Expression of immunologically reactive aids viral protein
RU93005170A (ru) Нуклеиновые кислоты, применение нуклеиновых кислот, диагностические наборы, вакцины, клетки, белок, применение белка, антитела, применение антител
ATE163766T1 (de) Synthetisches antigen zum nachweis von mit aids in zusammenhang stehenden krankheiten
EP0476130A4 (en) Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof
DE69432043D1 (de) Diagnostische Reagenzien zum Nachweis von Antikörper gegen EBV
EP0248534A3 (de) Verfahren zum Nachweis einer AIDS-Virus-Infektion
ATE389018T1 (de) Cx3c chemokin-gene von säugetieren
ATE236405T1 (de) Western blot test zur identifizierung von hcmv spezifische antiköpern
ATE108457T1 (de) Synthetische antigene zur bestimmung der aids- bezogenen, von lav-2 verursachten krankheiten.
ATE360709T1 (de) Synthetische antigene zum nachweis von antikörpern mit immunreaktivität gegen hiv-virus
ES2282847T3 (es) Peptidos derivados del antigeno de la capside de vca-p18 del virus de epstein-barr y su uso.
ES2024734A6 (es) Procedimiento de obtencio de un metodo de ensayo para el virus de la peste porcina africana (vppa).
DE59610867D1 (de) Rekombinante autologe Fusionsproteine des Epstein-Barr-Virus, diese enthaltende Testkits und Verfahren zum Nachweis von Epstein-Barr-Virus-spezifischen Antikörpern
HK1000788A (en) Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof
Kaaden New, sensitive diagnostic tests for the detection of viral diseases.).
KR950000879A (ko) 신규한 인간 면역결핍 바이러스-2(hiv-2)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0920629

Country of ref document: EP

REN Ceased due to non-payment of the annual fee